Search
Powered By HealthLine
Health Tools
 Cold & Flu Remedies
 Symptoms Checker
 Quiz: Cold & Flu Myths
 Flu Vaccine Guide
 Avian Flu Guide
Featured Conditions
 Cold & Flu
 Allergy
 Diet & Exercise
 Depression
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Flu Vaccine Safe for Infants 6 Weeks Old

Babies younger than 6 months could be safely protected, researcher says


Related Encyclopedia
 border=
Abscess
Acne
Actinomycosis
Acute Myeloid Leukemia (Adult)
More...

Related Healthscout Videos
 border=
Reconstructing ACL's in Kids
Saving Derek from Paralysis
Cat Scratch Fever - Hidden Killer
Vision Revision for ADHD Diagnosis
More...

Related Animations
 border=
Dental Cavities
More...

Related Drug Information
 border=
Abilify
Adderal XR
Augmentin
Bactroban Cream
More...

Related News Articles
 border=
Quality of Family Mealtimes May Affect Kids' Asthma
Good Child Care May Help Make Up for Troubled Homes
Bilingual People More Adept at Learning Third Language
Rare Children's Strokes Sometimes Misdiagnosed
More...

WEDNESDAY, Feb. 10 (HealthDay News) -- Seasonal flu vaccines are safe and effective in infants as young as 6 to 12 weeks, new research claims.

These findings, which need to be confirmed in more studies, suggest that seasonal flu vaccine should be included in standard vaccinations for infants less than 6 months old, said Dr. Janet A. Englund, of the University of Washington, Seattle, and colleagues.

Text Continues Below



No flu vaccine is approved for use in infants less than 6 months old, even though children in this age group are at high risk for flu and related complications.

In this study, the researchers randomly assigned 1,375 healthy infants to receive either two doses of the standard trivalent seasonal flu vaccine (protects against three strains of circulating flu virus) or a placebo vaccine. The vaccines were given one month apart, in combination with standard recommended infant vaccines.

No differences were seen between the two groups of infants in terms of side effects or adverse events. About 11 percent of infants in both groups developed a fever within three days after vaccination. In the month after vaccination, serious adverse events related to the trivalent vaccine were rare, according to the study.

Immunological tests showed that nearly half of the infants who received the flu vaccine developed protective antibodies against at least two of the three influenza strains covered by the vaccine. No evidence was noted that the flu vaccine interfered with infant responses to routine childhood vaccinations.

"Based on the results of this study, potential protection against influenza could be safely obtained in infants less than 6 months old of age who receive standard infant dose of inactivated influenza vaccine," Englund and colleagues concluded.

The study is published in the February issue of The Pediatric Infectious Disease Journal.

More information

The U.S. Centers for Disease Control and Prevention has more about children and influenza.



-- Robert Preidt

Copyright © 2010 HealthDay. All rights reserved.
Last updated 2/10/2010

Related Links
 border=
From Healthscout's partner site on allergy, MyAllergyNetwork.com
QUIZ: Test your knowledge of allergy causes and treatments
DRUGS: Common drugs used to treat allergies
SYMPTOMS: Images and information on allergy symptoms




SOURCE: The Pediatric Infectious Disease Journal, news release, February 2010


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2011. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire